A citation-based method for searching scientific literature

Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
Times Cited: 97



Barbara Heidenreich, Eduardo Nagore, P Sivaramakrishna Rachakonda, Zaida Garcia-Casado, Celia Requena, Victor Traves, Jürgen Becker, Nadem Soufir, Kari Hemminki, Rajiv Kumar. Nat Commun 2014
Times Cited: 115




List of shared articles



Times cited

Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential.
Stina George Fernandes, Rebecca Dsouza, Gouri Pandya, Anuradha Kirtonia, Vinay Tergaonkar, Sook Y Lee, Manoj Garg, Ekta Khattar. Cancers (Basel) 2020
10

Diverse regulatory manners of human telomerase reverse transcriptase.
Meng-Meng Jie, Xing Chang, Shuo Zeng, Cheng Liu, Guo-Bin Liao, Ya-Ran Wu, Chun-Hua Liu, Chang-Jiang Hu, Shi-Ming Yang, Xin-Zhe Li. Cell Commun Signal 2019
8

TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Juan J Andrés-Lencina, Sivaramakrishna Rachakonda, Zaida García-Casado, Nalini Srinivas, Alexander Skorokhod, Celia Requena, Virtudes Soriano, Rajiv Kumar, Eduardo Nagore. Int J Cancer 2019
21

TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
14


Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.
Semih Can Akıncılar, Ekta Khattar, Priscilla Li Shan Boon, Bilal Unal, Melissa Jane Fullwood, Vinay Tergaonkar. Cancer Discov 2016
82

Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.
Teisha J Rowland, Gabrijela Dumbović, Evan P Hass, John L Rinn, Thomas R Cech. Proc Natl Acad Sci U S A 2019
11

Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma.
Emilia Hugdahl, May Britt Kalvenes, Monica Mannelqvist, Rita G Ladstein, Lars A Akslen. Br J Cancer 2018
21

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
77

Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Christine Pirker, Agnes Bilecz, Michael Grusch, Thomas Mohr, Barbara Heidenreich, Viktoria Laszlo, Paul Stockhammer, Daniela Lötsch-Gojo, Johannes Gojo, Lisa Gabler,[...]. Clin Cancer Res 2020
5

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma.
Yujiro Hayashi, Kazutoshi Fujita, George J Netto, Norio Nonomura. Front Oncol 2021
0

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.
Andrelou F Vallarelli, P Sivaramakrishna Rachakonda, Jocelyne André, Barbara Heidenreich, Laurence Riffaud, Armand Bensussan, Rajiv Kumar, Nicolas Dumaz. Oncotarget 2016
35

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Muhammad Khairul Ramlee, Jing Wang, Wei Xun Toh, Shang Li. Genes (Basel) 2016
70

TERT biology and function in cancer: beyond immortalisation.
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. J Mol Endocrinol 2017
36

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers.
Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou. NPJ Precis Oncol 2021
1

Understanding TERT Promoter Mutations: A Common Path to Immortality.
Robert J A Bell, H Tomas Rube, Ana Xavier-Magalhães, Bruno M Costa, Andrew Mancini, Jun S Song, Joseph F Costello. Mol Cancer Res 2016
114

Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma.
Maria Giovanna Maturo, Sivaramakrishna Rachakonda, Barbara Heidenreich, Cristina Pellegrini, Nalini Srinivas, Celia Requena, Carlos Serra-Guillen, Beatriz Llombart, Onofre Sanmartin, Carlos Guillen,[...]. Sci Rep 2020
6

TERT promoter mutations in telomere biology.
Barbara Heidenreich, Rajiv Kumar. Mutat Res Rev Mutat Res 2017
76

Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
Yinghui Li, Hui Shan Cheng, Wee Joo Chng, Vinay Tergaonkar. Proc Natl Acad Sci U S A 2016
53

The Solo Play of TERT Promoter Mutations.
François Hafezi, Danielle Perez Bercoff. Cells 2020
8

TERT gene: its function and dysregulation in cancer.
Andrew J Colebatch, Alexander Dobrovic, Wendy A Cooper. J Clin Pathol 2019
18

Telomeres and Telomere Length: A General Overview.
Nalini Srinivas, Sivaramakrishna Rachakonda, Rajiv Kumar. Cancers (Basel) 2020
26


TERT promoter mutations in melanoma survival.
Eduardo Nagore, Barbara Heidenreich, Sívaramakrishna Rachakonda, Zaida Garcia-Casado, Celia Requena, Virtudes Soriano, Christoph Frank, Victor Traves, Esther Quecedo, Josefa Sanjuan-Gimenez,[...]. Int J Cancer 2016
68

Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Sivaramakrishna Rachakonda, Haiying Kong, Nalini Srinivas, Zaida Garcia-Casado, Celia Requena, Mahdi Fallah, Barbara Heidenreich, Dolores Planelles, Victor Traves, Dirk Schadendorf,[...]. Genes Chromosomes Cancer 2018
21